Pacific Biosciences

205 articles with Pacific Biosciences

• 

  Top 12 Biotech Companies Hiring Now

  12/7/2021

  Life sciences professionals are mixed as to whether the job market is in favor of the candidate or the employer. However, life sciences employers aren’t.

• Pacific Biosciences of California, Inc. Third Quarter 2021 Financial Results Call

  10/19/2021

  Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its third quarter 2021 financial results on Tuesday, November 2, 2021, at 4:30pm Eastern Time.

• Pacific Biosciences Grants Equity Incentive Award to New Employee - Sep 24, 2021

  9/24/2021

  Pacific Biosciences of California, Inc. announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 100,000 shares of Pacific Biosciences common stock, and restricted stock units covering 50,000 shares of Pacific Biosciences common stock, to a recently hired employee under the Pacific Biosciences 2020 Inducement Equity Incentive Plan effective on September 20, 2021.

• Pacific Biosciences Closes Acquisition of Omniome and Establishes San Diego Presence

  9/20/2021

  Pacific Biosciences of California, Inc. announced today the companies have closed the transaction under which Pacific Biosciences acquired Omniome.

• Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conferences - Sep 03, 2021

  9/3/2021

  Pacific Biosciences of California, Inc. announced that its executives will be speaking at the following investor conferences.

• Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conference - Aug 09, 2021

  8/9/2021

  Pacific Biosciences of California, Inc. announced that its executives will be speaking at the following investor conference:.

• Pacific Biosciences of California, Inc. Announces Second Quarter 2021 Financial Results

  8/3/2021

  Pacific Biosciences of California, Inc. announced financial results for the quarter ended June 30, 2021.

• Pacific Biosciences Signs Definitive Agreement to Acquire Omniome

  7/20/2021

  Pacific Biosciences of California, Inc., a leading provider of high-quality, long-read sequencing platforms, announced that it has signed a definitive merger agreement under which it will acquire Omniome, a San Diego-based company developing a highly differentiated, proprietary short-read sequencing platform capable of delivering high accuracy.

• Pacific Biosciences and Invitae Announce Intent to Expand Collaboration

  7/20/2021

  Pacific Biosciences of California, Inc., a leading provider of high-quality, long-read sequencing platforms, and Invitae Corporation, a leading medical genetics company, announced an intent to expand their multi-year collaboration to develop a production-scale high-throughput HiFi sequencing platform to include the sequencing technology developed by Omniome, Inc.

• Pacific Biosciences Welcomes Neil Ward to Its Leadership Team as Vice President and General Manager for Europe, Middle East, and AfricaIndustry Veteran Will Lead PacBio’s Commercial Footprint Across the Region

  6/8/2021

  Pacific Biosciences of California, Inc., a leading provider of high-quality, long-read sequencing platforms, welcomed Neil Ward to the new role of Vice President and General Manager for the company’s Europe, Middle East, and Africa region to expand and develop the team and infrastructure to capitalize on the immense potential for genomics in this area of the world.

• Pacific Biosciences Further Expands Leadership Team with Appointment of Dr. Catherine Ball to Newly Created Position of Senior Vice President of Research

  5/17/2021

  Kathleen Lynch has joined as Head of Global Government Affairs and Communications and Michele Farmer has joined as Chief Accounting Officer

• Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conferences - May 04, 2021

  5/4/2021

  Pacific Biosciences of California, Inc. announced that its executives will be speaking at the following investor conferences

• Pacific Biosciences of California, Inc. Announces First Quarter 2021 Financial Results

  4/29/2021

  Pacific Biosciences of California, Inc. announced financial results for the quarter ended March 31, 2021.

• Pacific Biosciences Launches New HiFi Sequencing Workflow to Further Improve HiFi’s Industry Leading Accuracy

  4/26/2021

  HiFi Sequencing and Software v10.1 Release on the Sequel II and IIe Systems I ncreases Scalability, Improves Usability, and Unlocks Additional Sample Types to Extend the Value of HiFi Reads

• Pacific Biosciences of California, Inc. First Quarter 2021 Financial Results Call

  4/15/2021

  Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its first quarter 2021 financial results on Thursday, April 29, 2021, at 4:30pm Eastern Time.

• Children’s Mercy Kansas City Expands Investment in Pacific Biosciences Sequel IIe Systems to Scale Up Whole Genome Research Initiatives Focused on Rare Disease Diagnosis

  2/24/2021

  Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that Children’s Mercy Kansas City, one of the nation’s top pediatric medical centers, has increased its investment in highly accurate HiFi sequencing with four new Sequel IIe Systems to add to its two existing Sequel IIe Systems.

• Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19Labcorp Using PacBio’s HiFi Sequencing to Detect SARS-CoV-2 Variants in the U.S.

  2/18/2021

  Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that Labcorp (NYSE: LH), a leading global life sciences company, has increased its commitment to highly accurate HiFi sequencing with the addition of new PacBio ® Sequel ® II Systems.

• 

  PacBio Secures $900 Million Investment to Support Gene Sequencing

  2/10/2021

  Shares of Pacific Biosciences soared more than 21% in premarket trading after it was announced SB Management, a subsidiary of SoftBank Group Corp., will make an investment of $900 million into the company to support its gene sequencing research.

• Pacific Biosciences Grants Equity Incentive Award to New Employee - Feb 05, 2021

  2/5/2021

  Pacific Biosciences of California, Inc. announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 100,000 shares of Pacific Biosciences common stock and restricted stock units covering 50,000 shares of Pacific Biosciences common stock to a recently hired employee under the Pacific Biosciences 2020 Inducement Equity Incentive Plan on December 14, 2020.

• Pacific Biosciences of California, Inc. Fourth Quarter 2020 Financial Results Call

  1/27/2021

  Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its fourth quarter 2020 financial results on Wednesday, February 10, 2021, at 4:30pm Eastern Time. The call will be webcast and may be accessed at Pacific Biosciences’ website at: https://investor.pacificbiosciences.com/ . Date: February 10, 2021 Time: 4:30pm ET Listen via Internet: https://investor.pacificbiosciences.com/ Toll